JP2009540812A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540812A5
JP2009540812A5 JP2009515886A JP2009515886A JP2009540812A5 JP 2009540812 A5 JP2009540812 A5 JP 2009540812A5 JP 2009515886 A JP2009515886 A JP 2009515886A JP 2009515886 A JP2009515886 A JP 2009515886A JP 2009540812 A5 JP2009540812 A5 JP 2009540812A5
Authority
JP
Japan
Prior art keywords
seq
mage
nos
primer
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009515886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540812A (ja
Filing date
Publication date
Priority claimed from GBGB0612342.6A external-priority patent/GB0612342D0/en
Application filed filed Critical
Publication of JP2009540812A publication Critical patent/JP2009540812A/ja
Publication of JP2009540812A5 publication Critical patent/JP2009540812A5/ja
Pending legal-status Critical Current

Links

JP2009515886A 2006-06-21 2007-06-21 Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法 Pending JP2009540812A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0612342.6A GB0612342D0 (en) 2006-06-21 2006-06-21 Method
PCT/EP2007/056219 WO2007147876A2 (en) 2006-06-21 2007-06-21 Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage- a3 -marker

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012245934A Division JP5705191B2 (ja) 2006-06-21 2012-11-08 Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法

Publications (2)

Publication Number Publication Date
JP2009540812A JP2009540812A (ja) 2009-11-26
JP2009540812A5 true JP2009540812A5 (cg-RX-API-DMAC7.html) 2010-07-15

Family

ID=36803668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009515886A Pending JP2009540812A (ja) 2006-06-21 2007-06-21 Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法
JP2012245934A Expired - Fee Related JP5705191B2 (ja) 2006-06-21 2012-11-08 Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012245934A Expired - Fee Related JP5705191B2 (ja) 2006-06-21 2012-11-08 Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法

Country Status (27)

Country Link
US (1) US8936919B2 (cg-RX-API-DMAC7.html)
EP (1) EP2041308B1 (cg-RX-API-DMAC7.html)
JP (2) JP2009540812A (cg-RX-API-DMAC7.html)
KR (1) KR101455589B1 (cg-RX-API-DMAC7.html)
CN (1) CN101506383B (cg-RX-API-DMAC7.html)
AU (1) AU2007263019B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0713599A2 (cg-RX-API-DMAC7.html)
CA (1) CA2656909A1 (cg-RX-API-DMAC7.html)
CO (1) CO6140072A2 (cg-RX-API-DMAC7.html)
CY (1) CY1113290T1 (cg-RX-API-DMAC7.html)
DK (1) DK2041308T3 (cg-RX-API-DMAC7.html)
EA (1) EA016347B1 (cg-RX-API-DMAC7.html)
ES (1) ES2389513T3 (cg-RX-API-DMAC7.html)
GB (1) GB0612342D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20120761T1 (cg-RX-API-DMAC7.html)
IL (1) IL195975A (cg-RX-API-DMAC7.html)
MA (1) MA30565B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008016493A (cg-RX-API-DMAC7.html)
MY (1) MY147511A (cg-RX-API-DMAC7.html)
NO (1) NO20085290L (cg-RX-API-DMAC7.html)
NZ (1) NZ573809A (cg-RX-API-DMAC7.html)
PL (1) PL2041308T3 (cg-RX-API-DMAC7.html)
PT (1) PT2041308E (cg-RX-API-DMAC7.html)
SI (1) SI2041308T1 (cg-RX-API-DMAC7.html)
UA (1) UA95956C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007147876A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200810695B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596545A (en) 2007-09-17 2013-05-31 Glaxosmithkline Biolog Sa Improved detection of mage-a expression
US8987423B2 (en) * 2010-07-22 2015-03-24 Glaxosmithkline Biologicals, S.A. MAGE antigen binding proteins
CN102251033B (zh) * 2011-07-05 2013-03-20 北京大学人民医院 基于mage-a3基因辅助诊断多发性骨髓瘤患者的定量检测试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612201A (en) * 1991-05-23 1997-03-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor
IL106610A0 (en) * 1992-08-07 1993-12-08 Cytel Corp Hla binding peptides and their uses
ATE209690T1 (de) * 1994-03-01 2001-12-15 Ludwig Inst Cancer Res Bestimmung krebsartiger beschaffenheiten durch die genexpression eines mitgliedes der melanomartigengruppe, mage
US5985571A (en) * 1998-02-04 1999-11-16 Ludwig Institute For Cancer Research Method for determining multiple myeloma by assaying for expression of mage genes
BR9907691B1 (pt) 1998-02-05 2011-05-31 derivado de antìgeno e antìgeno da famìlia mage associado a tumor, seqüência de ácido nucléico, codificando os mesmos, seus usos na preparação de vacina, processo para produção de vacina e vacina.
AU5992999A (en) 1998-10-02 2000-04-26 Ludwig Institute For Cancer Research Tumor antigens and ctl clones isolated by a novel procedure
JP3603138B2 (ja) * 2000-02-18 2004-12-22 独立行政法人理化学研究所 細胞死抑制タンパク質
US6358679B1 (en) * 2000-08-24 2002-03-19 Pe Corporation (Ny) Methods for external controls for nucleic acid amplification
US6635425B2 (en) * 2001-01-05 2003-10-21 Molecular Staging, Inc. 5′-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
DE60234115D1 (de) * 2001-11-29 2009-12-03 Dandrit Biotech As Pharmazeutische zusammensetzung zur auslösung einer immunantwort bei einem menschen oder einem tier
EP2305813A3 (en) 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
ATE522620T1 (de) * 2002-11-14 2011-09-15 Wayne John Cancer Inst Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr
GB0409940D0 (en) * 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
US20070231822A1 (en) * 2006-02-28 2007-10-04 Michael Mitas Methods for the detection and treatment of cancer

Similar Documents

Publication Publication Date Title
CN101932723B (zh) 改进的对mage-a表达的检测
JP2010538633A5 (cg-RX-API-DMAC7.html)
JP2012520663A5 (cg-RX-API-DMAC7.html)
KR20120002534A (ko) 유전자 발현의 향상된 검출
KR20190057305A (ko) 자궁내막증에 대한 바이오마커로서의 microRNAs
ES2425617T3 (es) Metilación de los promotores de MAL y de CADM1, marcador de diagnóstico molecular para cánceres cervicales invasivos inducidos por el VPH y sus lesiones precursoras de alto grado de malignidad
JP2008505644A5 (cg-RX-API-DMAC7.html)
JP2012100628A (ja) Eml4−alk融合遺伝子の高感度検出方法
JP5705191B2 (ja) Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法
KR101544531B1 (ko) 비알코올성 지방간염 감별용 바이오마커 miR-494-3p
WO2011104694A2 (en) Detection of braf v600e mutation by allele specific real time quantitative pcr (as-qpcr) using locked nucleic acids primers and beacon probes
KR20140054399A (ko) 암에서의 prame 유전자 발현의 검출
CN105838797B (zh) 一种诊治食管癌的分子标志物
KR101570269B1 (ko) 비알코올성 지방간염 감별용 바이오마커 miR-451
KR102108299B1 (ko) 위암의 림프절 전이를 예측하기 위한 마이크로rna 마커
JP2006520587A5 (cg-RX-API-DMAC7.html)
KR20140147920A (ko) 비알코올성 지방간염 감별용 바이오마커 miR-34a
杨晓峰 et al. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer
JP2016154521A (ja) Gistの予後又は治療抵抗性の診断
JP2013226074A (ja) 新規ddr2融合体
HK1170545A (en) A method for the assessment of cancer in a biological sample obtained from a subject
JP2013226075A (ja) 新規aurkc融合体